The Journal of Experimental Medicine
PBL InterferonSource
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents
Published 21 March 2005. doi:10.1084/jem.20041497
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 6, 871-879
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 1012K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by del Conde, I.
Right arrow Articles by Afshar-Kharghan, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by del Conde, I.
Right arrow Articles by Afshar-Kharghan, V.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

 Platelet activation leads to activation and propagation of the complement system

Ian del Conde, Miguel A. Crúz, Hui Zhang, José A. López, and Vahid Afshar-Kharghan

Thrombosis Research Section, Department of Medicine, Baylor College of Medicine, Houston, TX 77030

CORRESPONDENCE Vahid Afshar-Kharghan: vahid{at}bcm.tmc.edu

Inflammation and thrombosis are two responses that are linked through a number of mechanisms, one of them being the complement system. Various proteins of the complement system interact specifically with platelets, which, in turn, activates them and promotes thrombosis. In this paper, we show that the converse is also true: activated platelets can activate the complement system. As assessed by flow cytometry and immunoblotting, C3 deposition increased on the platelet surface upon cell activation with different agonists. Activation of the complement system proceeded to its final stages, which was marked by the increased generation of the anaphylotoxin C3a and the C5b-9 complex. We identified P-selectin as a C3b-binding protein, and confirmed by surface plasmon resonance binding that these two proteins interact specifically with a dissociation constant of 1 µM. Using heterologous cells expressing P-selectin, we found that P-selectin alone is sufficient to activate the complement system, marked by increases in C3b deposition, C3a generation, and C5b-9 formation. In summary, we have found that platelets are capable of activating the complement system, and have identified P-selectin as a receptor for C3b capable of initiating complement activation. These findings point out an additional mechanism by which inflammation may localize to sites of vascular injury and thrombosis.

Abbreviations used: CR, complement receptor; CHO, Chinese hamster ovary; CHO-P; CHO expressing P-selectin; HUS, hemolytic uremic syndrome; PNH, paroxysmal nocturnal hemoglobinuria; PPP, platelet-poor plasma; PRP, platelet-rich plasma; TRAP, thrombin receptor–activating peptide.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS